Abstract
Antituberculosis activity of several 5-(4-aminophenyl)-4-alkyl/aryl-2,4-dihydro-3H-1,2,4-triazole-3-thiones (1- 9) and their thiourea derivatives (10-31) were screened for their antimycobacterial activities against Mycobacterium tuberculosis H37Rv using the BACTEC 460 radiometric system. Of the synthesized compounds, 10-12, 30 were the most active derivatives exhibiting more than 90 % inhibition of mycobacterial growth at 12.5 μg/mL. Structure-activity relationships study was performed for the given series by using the Electronic-Topological Method combined with Neural Networks (ETM-NN). A system of prognosis was developed as the result of training associative neural network (ASNN) using weights of pharmacophoric fragments as descriptors. Descriptors were calculated by the projection of ETM compound and pharmacophoric fragments on the elements of Kohonens self-organizing maps (SOM). From the detailed analysis of all compounds under study, the necessary requirements for a compound to possess antituberculosis activity were formulated. The analysis have shown that any requirements violation for a molecule implies a considerable decrease or even complete loss of its activity.
Keywords: Antituberculosis activity, structure-activity relationships, electronic-topological method, neural networks
Medicinal Chemistry
Title: The Structure - Antituberculosis Activity Relationships Study in a Series of 5-(4-Aminophenyl)-4-Substituted-2,4-Dihydro-3h-1,2,4-Triazole-3-Thione Derivatives. A Combined Electronic-Topological and Neural Networks Approach
Volume: 2 Issue: 4
Author(s): Fatma Kandemirli, Nathali Shvets, Seda Unsalan, Ilkay Kucukguzel, Sevim Rollas, Vasyl Kovalishyn and Anatholy Dimoglo
Affiliation:
Keywords: Antituberculosis activity, structure-activity relationships, electronic-topological method, neural networks
Abstract: Antituberculosis activity of several 5-(4-aminophenyl)-4-alkyl/aryl-2,4-dihydro-3H-1,2,4-triazole-3-thiones (1- 9) and their thiourea derivatives (10-31) were screened for their antimycobacterial activities against Mycobacterium tuberculosis H37Rv using the BACTEC 460 radiometric system. Of the synthesized compounds, 10-12, 30 were the most active derivatives exhibiting more than 90 % inhibition of mycobacterial growth at 12.5 μg/mL. Structure-activity relationships study was performed for the given series by using the Electronic-Topological Method combined with Neural Networks (ETM-NN). A system of prognosis was developed as the result of training associative neural network (ASNN) using weights of pharmacophoric fragments as descriptors. Descriptors were calculated by the projection of ETM compound and pharmacophoric fragments on the elements of Kohonens self-organizing maps (SOM). From the detailed analysis of all compounds under study, the necessary requirements for a compound to possess antituberculosis activity were formulated. The analysis have shown that any requirements violation for a molecule implies a considerable decrease or even complete loss of its activity.
Export Options
About this article
Cite this article as:
Kandemirli Fatma, Shvets Nathali, Unsalan Seda, Kucukguzel Ilkay, Rollas Sevim, Kovalishyn Vasyl and Dimoglo Anatholy, The Structure - Antituberculosis Activity Relationships Study in a Series of 5-(4-Aminophenyl)-4-Substituted-2,4-Dihydro-3h-1,2,4-Triazole-3-Thione Derivatives. A Combined Electronic-Topological and Neural Networks Approach, Medicinal Chemistry 2006; 2 (4) . https://dx.doi.org/10.2174/157340606777724013
DOI https://dx.doi.org/10.2174/157340606777724013 |
Print ISSN 1573-4064 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6638 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Scanning the Genome of Mycobacterium tuberculosis to Identify Potential Lectins
Protein & Peptide Letters Fish and Apoptosis: Studies in Disease and Pharmaceutical Design
Current Pharmaceutical Design Randomized Clinical Trials in Children - Ethical and Methodological Issues
Current Pharmaceutical Design Fluoroquinolones: Blessings Or Curses
Current Drug Targets Strain Typing of Mycoplasma pneumoniae and its Value in Epidemiology
Current Pediatric Reviews Inclusion Complexation Behaviors of 3-Tigloyl-Azadirachtol with β-Cyclodextrin Derivatives
Current Pharmaceutical Analysis Tuberculosis Treated by Multiple Drugs: An Overview
Current Drug Delivery Trypanocidal Activity of Nitroaromatic Prodrugs: Current Treatments and Future Perspectives
Current Topics in Medicinal Chemistry Defining ‘Satisfactory Response’ to Therapy in Abdominal Tuberculosis: A Work in Progress
Infectious Disorders - Drug Targets Mucosal Vaccines: Where Do We Stand?
Current Topics in Medicinal Chemistry Meet the Editorial Board:
Current Medicinal Chemistry Ascorbic Acid: An Old Player with a Broad Impact on Body Physiology Including Oxidative Stress Suppression and Immunomodulation: A Review
Mini-Reviews in Medicinal Chemistry Meet Our Editorial Board Member
The Natural Products Journal Targeted Drugs and Nanomedicine: Present and Future
Current Pharmaceutical Design Targeting Th2 Cells in Asthmatic Airways
Current Drug Targets - Inflammation & Allergy Mechanism of Conjugated Imine and Iminium Species, including Marine Alkaloids: Electron Transfer, Reactive Oxygen Species, Therapeutics and Toxicity
Current Bioactive Compounds Vitamin D is Related to Markers of Vulnerable Plaque in Acute Myocardial Infarction
Current Vascular Pharmacology Meet Our Editorial Board Member
Current Drug Discovery Technologies Hemoglobin Degrading Proteases of Plasmodium falciparum as Antimalarial Drug Targets
Current Drug Targets TNF alpha Inhibition as Treatment Modality for Certain Rheumatologic and Gastrointestinal Diseases
Endocrine, Metabolic & Immune Disorders - Drug Targets